Sounds like a distraction to me. They're supposed to be focused on the high margin side of things, and this ain't it. I'd surely suspect that the take-up and prescription of these products would be multiples lower than that of cannabis so I see the upside.
At least the loan is on good terms so they're generating income from some of that cash.
Ann: Psychedelic joint venture with PharmAla Biotech, page-4
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
